<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4139</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2021.131922</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Study of Ocular Manifestations in Systemic Malignancies&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>M.</surname><given-names>Khochikar Nilima</given-names></name></contrib><contrib contrib-type="author"><name><surname>VH</surname><given-names>Karambelkar</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>11</day><month>10</month><year>2021</year></pub-date><volume>9)</volume><issue/><fpage>70</fpage><lpage>75</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: Primary ophthalmic tumours are well known, but the eye is a rare site for disseminated malignancy. The eye and orbit can get affected by cancer due to the direct effect of metastatic neoplastic infiltration or compression or by circulating anti-bodies involving paraneoplastic retinal degeneration. Aim: The present study aims to objectify the ocular manifestations in systemic malignancies. Methodology: This cross-sectional study was conducted on patients presenting with systemic malignancies to the out-patient department of Krishna Hospital Karad, Maharashtra, from December 2018 to May 2020. Result: Ophthalmic manifestations were seen in 21.77% of patients with systemic malignancies. Conclusion: All patients with systemic malignancies (primary and metastatic) should undergo a thorough ophthalmic examination regularly to prevent visual loss.&#13;
</p></abstract><kwd-group><kwd> Ocular manifestations</kwd><kwd> Systemic malignancies</kwd><kwd> Metastatic</kwd><kwd> Visual loss</kwd><kwd> Ophthalmic</kwd><kwd> Antibodies</kwd></kwd-group></article-meta></front></article>
